This is a wonderful announcement and come February 1st there will be a lot of pent up demand and anticipation on behalf of the surgical community for who this product is relevant. I think we'll see a significant contribution to the March quarterly figure from 3D.
CardioCel3D is a completely unique product, a disruptive technology and demand will be very strong from the outset.
Ann: Update on Admedus shaped patch product franchise, page-12
-
- There are more pages in this discussion • 46 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$12.50 |
Change
-0.400(3.10%) |
Mkt cap ! $264.2M | |||
| Open | High | Low | Value | Volume |
| $12.71 | $12.71 | $12.30 | $131.3K | 10.46K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 85 | $11.62 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.50 | 276 | 1 |
View Market Depth
| Last trade - 16.10pm 18/09/2024 (20 minute delay) ? |
| AVR (ASX) Chart |